ending CDC, V R36, period limitations for date FDA, 2.0 UH2 this FOA. Applications that do not comply with these instructions = Y VA, may be delayed or USU not accepted for review. SF N N Incl: Incl Incl: R01, Provide error if project The project period for E Update to NIH, : R21/R33, existing rule period is more than this type of project CDC, V (added DP1, five years long. application is limited ending FDA, 2.0 U01, DP2, DP3, to five years. date RF1, DP4, DP5 = UF1, and UP5) N VA, K02, USU K05, January 14, K24, 2016 K26, Release, K01, Update to K07, Existing Rule K08, (added K76) K18, K22, K23, K25, K99, K99/R00, R61/R33, DP1, ROO, DP2, DP3, DP4, DP5 and UP5, K76, I80
ending date CDC, FDA, VA, USU V 2.0 = Y R36, UH2 period limitations for this FOA. Applications that do not comply with these instructions may be delayed or not accepted for review. SF project ending date N N Incl: NIH, CDC, FDA, VA, USU V 2.0 = N Incl: R01, R21/R33, U01, RF1, UF1, K02, K05, K24, K26, K01, K07, K08, K18, K22, K23, K25, K99, K99/R00, R61/R33, DP1, ROO, DP2, DP3, DP4, DP5 and UP5, K76, I80 Provide error if project period is more than five years long. The project period for this type of application is limited to five years. E Update to existing rule (added DP1, DP2, DP3, DP4, DP5 and UP5) January 14, 2016 Release, Update to Existing Rule (added K76) : Incl
eSub-validations-draft-09-12-2017.docx